Parties to an MRA do not need to change their technical rules and that is why the UK government is now proposing MRA for compliance assessment as part of its new trade agreements. Washington, D.C. – February 14, 2019, U.S. Deputy Trade Representative C.J. Mahoney and Ambassador Kim Darroch, U.K. Ambassador to the United States, have signed two Mutual Recognition Agreements (MMA) on telecommunications equipment, electromagnetic compatibility (EMC) for information and communication technology products, inspections of good pharmaceutical manufacturing practices (GMP) and ship equipment. These MMAs with the United Kingdom replicate the material provisions of existing MRAs between the United States and the European Union for these sectors and will ensure that trade between the United States and the United Kingdom in these product sectors is not disrupted if the United Kingdom leaves the European Union. U.S. exports of products covered by these agreements to the United Kingdom exceeded $5 billion in 2018. The first scenario examines the assumptions that an agreement between the UK and the EU will not be concluded in time, so WTO rules would apply from 1 January 2021.
A simple free trade agreement would allow the removal of all tariffs on trade in goods for all sectors under the second scenario, an assumption that the report considers realistic. The third provides that non-tariff measures (NBMs) will also be included in the free trade agreement, such as cooperation. B cooperation with GMP regulations, inspections and batch testing through a mutual recognition agreement. Representatives of the pharmaceutical industry support the negotiation of a mutual recognition agreement between the EU and the UK to ensure good management of the production and distribution of medicines on both sides of the Channel in the scenarios envisaged for the final phase of Brexit, usually concluded with candidate countries with which the EU has entered into association agreements (see our rapporteur on association agreements) and which constitute a step in the process. The aim of the EPCA is to bring the technical rules of a candidate country in line with those of the EU in terms of preparation for EU membership. This type of MRA is by nature temporary, as it disappears when the country joins the EU internal market. For example, the European Commission`s recent free trade agreements with Canada and Korea provide for the conclusion of a compliance assessment MMA, without asking their partners to adapt their regulatory requirements to those of the EU. It is essential that “traditional” MRA does not require states to harmonize the rules (i.e. establishing technical standards and common rules) and do not require parties to one MRA to recognize each other`s requirements as equivalent – MRA is limited to the recognition of the partner`s CAB`s responsibility for assessing compliance. Trade agreements are trade agreements designed to facilitate market access and promote greater international harmonization of compliance standards while protecting consumer safety.
Although there has been little progress in accession negotiations, Turkey has gradually expanded its legislation on EU legislation to remove technical barriers. The results of THE CAB tests notified by Turkey are mutually recognised in the EU (and vice versa). A traditional MRA is a mutual recognition agreement for “compliance assessment.” The transition period for medicines for human use, which is covered by the agreement, ended on July 11, 2019: the MRA with Israel is an agreement on the evaluation of compliance and acceptance of industrial products (ACAA). It is a specific type of MRI based on the alignment of the legal system and infrastructure of the country concerned with that of the EU. The United Kingdom and the United States also signed an agreement on mutual recognition of marine equipment (MRA) today. This will ensure the continuity of the IMPACT of the EU-US MRA, when the EU-US INTER agreement does not apply